IMN is producing a virtual conference on Biotech ABS in late November. The sector has seen over $60Bn of issuance already in 2020 driven primarily by healthcare investing since Covid-19 outbreak. The event will include panel sessions focusing on the US and European markets, as well as panels covering the asset class globally.
IMN is asking FIIN members actively investing in the sector to join the conference as panel moderators and discussants. Programming is currently underway and if interesting please contact Lauren Kerr on email@example.com.